Director, Device Development and Commercialization Lead

Confirmed live in the last 24 hours

Vaxcyte

Compensation

$219,000 - $256,000/year

San Carlos, California, United States

On-site

Posted March 9, 2026

Job Description

Join our Mission to Protect Humankind!

Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance.

WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values:

*RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered.

*AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind.

*LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives.

*MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making.

Summary:

VAX-31 is an extremely complex biological product whereby numerous (31) Drug Substances are presented as an adjuvanted suspension Drug Product (DP). The complexity of the DP necessitates careful consideration for development of a pre-filled syringe (PFS) combination product for clinical and commercial use. Vaxcyte is looking for an energetic and talented individual to join our Drug Product Development Team to drive this combination product through the development and regulatory stage gates required for commercial success and distribution.

The Vax-31DP is a suspension system, which generates a unique set of challenges for production, handling and testing. All these complexities present themselves within the combination device setting, and the incumbent will be tasked with managing these through their own team and within a matrix format through the wider DP/commercial organization. In addition, these complexities need to be understood, managed and presented to the regulators in convincing and coherent regulatory submissions. Because of these complexities, experience in the vaccine space, particularly adjuvanted vaccines would be a distinct advantage.

This is an SME position which is suited for someone who has significant late-stage experience in leading the technical combination product workstream for a PFS/biologic combination product. Experience with combination product design control requirements and generation of associated documentation is required. As a core member of the DP Technical Team they will work closely with MSAT, CMO, Supply Chain, QC, QA and Clinical teams to ensure the appropriate Device Design requirements, including formal verification testing are met for use in clinical studies and global marketing submissions. They will work closely with the Regulatory and Quality teams to ensure the appropriate 21 CFR Part 4 and 820.3 compliant documentation is produced to support both clinical studies, marketing applications and continued commercial life cycle management.

This is a unique opportunity to be involved in arguably the most complex Drug Product to enter clinical testing and commercial readiness, be a crucial part of late stage enablement and long-term commercial success, which will affect millions of lives globally.

Essential Functions:

Lead combination device development activities through clinical development, tech transfer, commercial manufacturing, registration, launch and post market surveillance.
Guide the DP team on the necessary technical/CMC requirements for compliance with 21 CFR Part 4 and Part 820.3 and implement into the Combination Product program plan.
Responsible for development of design control documents and maintaining design history file (DHF) and Device Master Record (DMR) for the Vax-31 vaccine product.
Collaborate with internal cross-functional teams and external partners to develop and execute device specific plans to ensure clinical and launch milestones

goaidataproductdesignmarketing